Giuseppe Procopio

Papers authored by Giuseppe Procopio

This paper was not found in any repository, but could be made available legally by the author.

2014 Roberto Iacovelli, Filippo de Braud, Elena Verzoni, Paolo Grassi, Alessio Farcomeni, F. De Braud, Giuseppe Procopio

Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

P. Biondani, E. Verzoni, Torri, L. Porcu, P. Grassi, I. Testa, F. De Braud, G. Procopio

Sequential tyrosine kinase inhibitors (TKIs) in metastatic renal cell carcinoma: Results from a large cohort of patients

Upload

2013 Paolo Grassi, Elena Verzoni, Luigi Mariani, Filippo De Braud, Jorgelina Coppa, Vincenzo Mazzaferro, Giuseppe Procopio

Prognostic Role of Pancreatic Metastases From Renal Cell Carcinoma: Results From an Italian Center

Upload

Roberto Iacovelli, Elena Verzoni, Filippo De Braud, Giuseppe Procopio

First line treatment of metastatic renal cell carcinoma

Upload

This paper is made freely available by the publisher.

Elena Verzoni, Filippo de Braud, Francesca Fabiani, Paolo Grassi, Isabella Testa, Giuseppe Procopio

Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity

Download from doi.org

Roberto Iacovelli, A. Altavilla, G. Procopio

, S. Bracarda, M. Santoni, S. Cascinu, Enrico Cortesi

Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials

Download from www.nature.com

This paper is available in a repository.

Roberto Iacovelli, Giacomo Cartenì, Cora N. Sternberg, Michele Milella, Matteo Santoni, Giuseppe Di Lorenzo, Cinzia Ortega, Roberto Sabbatini, Riccardo Ricotta, Caterina Messina, Vito Lorusso, Francesco Atzori, Fabio De Vincenzo, Cosimo Sacco, Francesco Boccardo and 9 other authors

Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort

Download from www.researchgate.net

Roberto Sabbatini, Cinizia Ortega, Giuseppe Procopio

, Cristina Masini

, Enzo Galligioni, Camillo Porta

Metastatic renal cell carcinoma: how to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor

Download from doi.org

Lara Bellardita

, Tiziana Rancati, Maria Francesca Alvisi

, Daniela Villani, Tiziana Magnani, Cristina Marenghi, Nicola Nicolai, Giuseppe Procopio

, Sergio Villa, Roberto Salvioni, Riccardo Valdagni

Predictors of Health-related Quality of Life and Adjustment to Prostate Cancer During Active Surveillance

Download from www.researchgate.net

G. Procopio

, J. Bellmunt, J. Dutcher, S. Bracarda, J. Knox, A. Brueckner, I. Molnar, B. Escudier, T. E. Hutson

Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis

Download from www.nature.com

Elena Verzoni, Enrico Garanzini, Giuseppe Procopio

Complete responses in advanced renal cell carcinoma: Utopia or real chance?

Upload

G. Procopio

, E. Verzoni, S. Bracarda, S. Ricci, C. Sacco, L. Ridolfi, C. Porta, R. Miceli, N. Zilembo, E. Bajetta, Italian Trials in Medical Oncology (ITMO) Group

Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial.

Download from hdl.handle.net

Daniele Santini, Giuseppe Procopio

, Fedeli Sl, Camillo Porta, Toni Ibrahim, Sandro Barni, Calogero Mazzara, Andrea Fontana, Alfredo Berruti, Rossana Berardi, Bruno Vincenzi

, Cinzia Ortega, Davide Ottaviani, Giacomo Carteni, Gaetano Lanzetta and 18 other authors

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey.

Download from doi.org

C. Paglino, G. Procopio

, R. Sabbatini, J. Bellmunt, M. Schmidinger, A. Bearz, A. Bamias, B. Melichar, I. Imarisio, C. Tinelli, C. Porta

A retrospective analysis of two different sequences of therapy lines for advanced kidney cancer

Upload

2012 Camillo Porta, Roberto Sabbatini, Giuseppe Procopio

, Chiara Paglino, Enzo Galligioni, Cinzia Ortega

Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science

Upload

Giuseppe Procopio

, Elena Verzoni, Filippo de Braud

Targeted Therapies and Survival: What We Can Learn from Studies in Advanced Renal Cell Carcinoma

Download from www.karger.com

G. Procopio

, E. Verzoni, Roberto Iacovelli, D. Biasoni, I. Testa, L. Porcu, F. De Braud

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies

Download from www.nature.com

Amelia Altavilla, Roberto Iacovelli, Giuseppe Procopio

, Daniele Alesini, Emanuela Risi, Giuseppe Maria Campennì, Antonella Palazzo, Enrico Cortesi

Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant

Download from europepmc.org

Giuseppe Procopio

, Elena Verzoni, Isabella Testa, Nicola Nicolai, Roberto Salvioni, Filippo DeBraud

Experience with sorafenib in the treatment of advanced renal cell carcinoma

Download from journals.sagepub.com

Giuseppe Procopio

, Roberto Sabbatini, Camillo Porta, Elena Verzoni, Enzo Galligioni, Cinzia Ortega

Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinoma

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Giuseppe Procopio